Drugs and Therapy Bulletin
Drugs & Therapy Bulletin is a monthly publication by the Department of Pharmacy Services and the Pharmacy and Therapeutics Committee of Shands at the University of Florida. Each month, this newsletter highlights the most important drug topics that challenge our department.
The contents of our most recent volumes are listed below. Please click on the desired issue to view the .pdf document. For older issues, please visit our archive page.
2013 Volume 27
May, Number 5
- Formulary Update
- The Route Less Traveled
- High-priority, Restricted-distribution drugs
April, Number 4
- Formulary Update
- Formulary Categories
- A New Online Formulary
- Nursing’s Medication and Administration Policy
March, Number 3
- Formulary Update
- Why isn’t hydrocodone listed in the Formulary?
- Alternatives when an NSAID fails?
February, Number 2
- Formulary Update
- Drug Dosing in Renal Impairment
- New Drugs in 2012
January, Number 1
- Formulary Update
- Why we still use animal products
- New C. difficile treatment algorithm endorsed
2012 Volume 26
November/December, Number 10
- Formulary Update
- Delete codeine from the Formulary?
- Compounding pharmacies and fungal meningitis
- 2012 Annual index
October, Number 9
- Formulary Update
- Oral Contraceptives and Thromboembolic Risk
- Medication Safety Subcommittee
- CYP2C19 Reporting Changes
August/September, Number 8
- Formulary Update
- Can dabigatran CAUSE clots?
July, Number 7
- Formulary Update
- Medicaid restricts oxycodone prescribing for children
- Should the inpatient use of TNF-alpha drugs be restricted?
June, Number 6
- Formulary Update
- Don’t get burned: Use sunscreen appropriately
May, Number 5
- Formulary Update
- Updated pharmacokinetic consult policy
- Mandatory Oral Hypotensive Administration Instructions
- Anticoagulation Management at Shands at UF
April, Number 4
- Formulary Update
- Update on Drug Shortages
- Is the PDR Obsolete?
March, Number 3
- Formulary Update
- Opioid Prescribing in “Naive” or “Tolerant” Patients
- Using Epic to Document Criteria for Use
- What’s all the hype…about hyperglycemia?
February, Number 2
- Formulary Update
- New Drugs in 2011
- Pardon My Language: What is PML?
- New Personalized Medicine Subcommittee
January, Number 1
- Formulary Update
- Three Routes of Acetaminophen:
Three Ways to Achieve the Same Result - Cardiovascular Drug-Induced DM
2011 – Volume 25
November/December 2011, Number 10 (pdf)
- Formulary Update
- The Formulary and the P&T Committee
- 2011 Annual Index
October 2011, Number 9 (pdf)
- Formulary Update
- Restrict IV acetylcysteine use for the prevention of radiocontrast- induced nephropathy
- Bisphosphonates and atypical femur fractures: A bone of contention
September 2011, Number 8 (pdf)
- Formulary Update
- New Florida law for controlled substances
July 2011, Number 7 (pdf)
- Formulary Update
- If to err is human, is CPOE divine?
- P&T committee-approved authorized changes to med lists
- Hey! Stop buggin’ me! General characteristics of insect repellants
June 2011, Number 6 (pdf)
- Formulary Update
- The truth about drug fever
May 2011, Number 5 (pdf)
- Formulary Update
- Prescription drug trends 2010
April 2011, Number 4 (pdf)
- Formulary Update
- What’s so special about specialty pharmacies?
- SALAS: Arista® versus Arixtra®
March 2011, Number 3 (pdf)
- Formulary Update
- Proposal: Delete IV Phenergan® from the Formulary
February 2011, Number 2 (pdf)
- Formulary Update
- Abandoned prescriptions?
- New drugs in 2011
January 2011, Number 1 (pdf)
- Formulary Update
- DTaP and Tdap: Understanding the letters
- Is erythromycin preferred to azithromycin as a prokinetic?
- Editorial: Twenty-five years of Bulletin